336 related articles for article (PubMed ID: 21999124)
1. Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer.
Ströhlein MA; Bulian DR; Heiss MM
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1505-8. PubMed ID: 21999124
[TBL] [Abstract][Full Text] [Related]
2. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
[TBL] [Abstract][Full Text] [Related]
3. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
[TBL] [Abstract][Full Text] [Related]
4. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
Yang XJ; Li Y; Yonemura Y
J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
[TBL] [Abstract][Full Text] [Related]
6. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
8. Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Weber T; Roitman M; Link KH
Clin Colorectal Cancer; 2012 Sep; 11(3):167-76. PubMed ID: 22397952
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
10. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
Pocard M; Boige V
Bull Cancer; 2005 Feb; 92(2):151-4. PubMed ID: 15749644
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment for peritoneal carcinomatosis from gastric cancer.
Yonemura Y; Endou Y; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Li Y
Eur J Surg Oncol; 2010 Dec; 36(12):1131-8. PubMed ID: 20933363
[TBL] [Abstract][Full Text] [Related]
12. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
13. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.
Roviello F; Caruso S; Neri A; Marrelli D
Eur J Surg Oncol; 2013 Dec; 39(12):1309-16. PubMed ID: 24183797
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
15. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
16. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
17. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
18. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology.
Omohwo C; Nieroda CA; Studeman KD; Thieme H; Kostuik P; Ross AS; Holter DR; Gushchin V; Merriman B; Sardi A
J Am Coll Surg; 2009 Sep; 209(3):308-12. PubMed ID: 19717034
[TBL] [Abstract][Full Text] [Related]
19. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
20. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.
Boerner T; Graichen A; Jeiter T; Zemann F; Renner P; März L; Soeder Y; Schlitt HJ; Piso P; Dahlke MH
Ann Surg Oncol; 2016 Nov; 23(12):3972-3977. PubMed ID: 27313067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
